These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28192171)

  • 21. Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient.
    Millucci L; Ghezzi L; Paccagnini E; Giorgetti G; Viti C; Braconi D; Laschi M; Geminiani M; Soldani P; Lupetti P; Orlandini M; Benvenuti C; Perfetto F; Spreafico A; Bernardini G; Santucci A
    Mediators Inflamm; 2014; 2014():258471. PubMed ID: 24876668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria.
    Ranganath LR; Milan AM; Hughes AT; Khedr M; Davison AS; Shweihdi E; Norman BP; Hughes JH; Bygott H; Luangrath E; Fitzgerald R; Psarelli EE; van Kan C; Laan D; Olsson B; Rudebeck M; Mankowitz L; Sireau N; Arnoux JB; Le Quan Sang KH; Jarvis JC; Genovese F; Braconi D; Santucci A; Zatkova A; Glasova H; Stančík R; Imrich R; Rhodes NP; Gallagher JA
    J Inherit Metab Dis; 2020 Jul; 43(4):737-747. PubMed ID: 31609457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homogentisic acid induces cytoskeleton and extracellular matrix alteration in alkaptonuric cartilage.
    Galderisi S; Cicaloni V; Milella MS; Millucci L; Geminiani M; Salvini L; Tinti L; Tinti C; Vieira OV; Alves LS; Crevenna AH; Spiga O; Santucci A
    J Cell Physiol; 2021 Aug; 236(8):6011-6024. PubMed ID: 33469937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ultrastructure of hyaline cartilage and articular capsule tissue in alkaptonuric ochronosis].
    Mohr W; Wessinghage D; Lenschow E
    Z Rheumatol; 1980; 39(3-4):55-73. PubMed ID: 7424200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cartilage biomarkers in the osteoarthropathy of alkaptonuria reveal low turnover and accelerated ageing.
    Taylor AM; Hsueh MF; Ranganath LR; Gallagher JA; Dillon JP; Huebner JL; Catterall JB; Kraus VB
    Rheumatology (Oxford); 2017 Jan; 56(1):156-164. PubMed ID: 28028161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis.
    Braconi D; Bianchini C; Bernardini G; Laschi M; Millucci L; Spreafico A; Santucci A
    J Inherit Metab Dis; 2011 Dec; 34(6):1163-76. PubMed ID: 21874298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutritional interventions for patients with alkaptonuria: A minireview.
    Imrich R; Zatkova A; Lukacova O; Sedlakova J; Zanova E; Vlcek M; Penesova A; Radikova Z; Havranova A; Ranganath L
    Endocr Regul; 2023 Jan; 57(1):61-67. PubMed ID: 36966367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre.
    Ranganath LR; Khedr M; Milan AM; Davison AS; Hughes AT; Usher JL; Taylor S; Loftus N; Daroszewska A; West E; Jones A; Briggs M; Fisher M; McCormick M; Judd S; Vinjamuri S; Griffin R; Psarelli EE; Cox TF; Sireau N; Dillon JP; Devine JM; Hughes G; Harrold J; Barton GJ; Jarvis JC; Gallagher JA
    Mol Genet Metab; 2018 Sep; 125(1-2):127-134. PubMed ID: 30055994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactive alkaptonuria database: investigating clinical data to improve patient care in a rare disease.
    Cicaloni V; Spiga O; Dimitri GM; Maiocchi R; Millucci L; Giustarini D; Bernardini G; Bernini A; Marzocchi B; Braconi D; Santucci A
    FASEB J; 2019 Nov; 33(11):12696-12703. PubMed ID: 31462106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alkaptonuria: From Molecular Insights to a Dedicated Digital Platform.
    Milella MS; Geminiani M; Trezza A; Visibelli A; Braconi D; Santucci A
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Untargeted NMR Metabolomics Reveals Alternative Biomarkers and Pathways in Alkaptonuria.
    Grasso D; Geminiani M; Galderisi S; Iacomelli G; Peruzzi L; Marzocchi B; Santucci A; Bernini A
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Melanin-like Pigment Synthesized from Homogentisic Acid, with or without Tyrosine, and Its Implications in Alkaptonuria.
    Taylor AM; Vercruysse KP
    JIMD Rep; 2017; 35():79-85. PubMed ID: 27943071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history of alkaptonuria revisited: analyses based on scoring systems.
    Ranganath LR; Cox TF
    J Inherit Metab Dis; 2011 Dec; 34(6):1141-51. PubMed ID: 21748407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alkaptonuria: clinical manifestations and an updated approach to treatment of a rare disease.
    Roopnarinesingh RC; Donlon NE; Reynolds JV
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34876442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria.
    Bernini A; Petricci E; Atrei A; Baratto MC; Manetti F; Santucci A
    Sci Rep; 2021 Nov; 11(1):22562. PubMed ID: 34799606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological and Ultrastructural Characterization of Alkaptonuric Tissues.
    Millucci L; Bernardini G; Spreafico A; Orlandini M; Braconi D; Laschi M; Geminiani M; Lupetti P; Giorgetti G; Viti C; Frediani B; Marzocchi B; Santucci A
    Calcif Tissue Int; 2017 Jul; 101(1):50-64. PubMed ID: 28271171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-Function Relationship of Homogentisate 1,2-dioxygenase: Understanding the Genotype-Phenotype Correlations in the Rare Genetic Disease Alkaptonuria.
    Bernini A; Spiga O; Santucci A
    Curr Protein Pept Sci; 2023; 24(5):380-392. PubMed ID: 36880186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuria.
    Norman BP; Sutherland H; Wilson PJM; Rutland DA; Milan AM; Hughes AT; Davison AS; Khedr M; Jarvis JC; Gallagher JA; Bou-Gharios G; Ranganath LR
    J Inherit Metab Dis; 2024 Jul; 47(4):664-673. PubMed ID: 38487984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anatomical Distribution of Ochronotic Pigment in Alkaptonuric Mice is Associated with Calcified Cartilage Chondrocytes at Osteochondral Interfaces.
    Hughes JH; Keenan CM; Sutherland H; Edwards HR; Wilson PJM; Ranganath LR; Jarvis JC; Bou-Gharios G; Gallagher JA
    Calcif Tissue Int; 2021 Feb; 108(2):207-218. PubMed ID: 33057760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of secondary amyloidosis in alkaptonuria.
    Millucci L; Ghezzi L; Bernardini G; Braconi D; Lupetti P; Perfetto F; Orlandini M; Santucci A
    Diagn Pathol; 2014 Sep; 9():185. PubMed ID: 25567001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.